P2Y receptors have been reported to modulate gastrointestinal functions. The newest family member is the nucleotide-sugar receptor P2Y 14 . P2ry14 mRNA was detected throughout the rat gut, with the highest level being in the forestomach. We investigated the role of the receptor in stomach motility using cognate agonists and knockout (KO) mice. In rat isolated forestomach, 100 μM UDP-glucose and 100 μM UDP-galactose both increased the baseline muscle tension (BMT) by 6.2±0.6 and 1.6±0.6 mN (P<0.05, n=3-4), respectively, and the amplitude of contractions during electrical field stimulation (EFS) by 3.7±1.7 and 4.3±2.5 mN (P<0.05, n=3-4), respectively. In forestomach from wild-type (WT) mice, 100 μM UDP-glucose increased the BMT by 1.0±0.1 mN (P <0.05, n=6) but this effect was lost in the KO mice (change of -0.1±0.1 mN, n=6). 100 μM UDPglucose also increased the contraction amplitude during EFS in this tissue from the WT animals (0.9±0.4 mN, P<0.05, n=6) but not from the KO mice (0. 0±0.2 mN, n=6) . In vivo, UDP-glucose at 2000 mg/kg i.p. reduced gastric emptying in rats by 49.7% (P<0.05, n=4-6), and in WT and KO mice by 56.1% and 66.2%, respectively (P<0.05, n=7-10) versus saline-treated control animals.
INTRODUCTION
Purinergic metabotropic (P2Y) receptors regulate a number of functions in the gastrointestinal (GI) tract in response to extracellular nucleotides. These include stomach relaxation (16) , smooth muscle hyperpolarization and relaxation in the colon (12) , muscle contraction in the colon (21), the generation of excitatory postsynaptic potentials via P2Y 1 in submucous neurons of the ileum, and epithelial ion transport via P2Y 2 and P2Y 4 in the jejunum (13) and colon (14) . The most recent addition to the P2Y family is the uridine 5'-diphosphate (UDP)-sugar receptor P2Y 14 (1) . The four reported cognate agonists have a rank order of potency at the recombinant human, mouse and rat receptors of UDP-glucose > UDP-galactose > UDP-glucuronic acid > UDP-N-acetylglucosamine (6), (11) . UDP-glucose and UDP-galactose are also less potent agonists at GPR17 (7) . In terms of homology with other receptors, P2Y 14 is closest to the adenine 5'-diphosphate (ADP) receptors P2Y 12 and P2Y 13 with 47% amino acid identity (2) . Within the seven transmembrane regions, the identity increases to 65% versus P2Y 13 followed by 48% versus P2Y 12 and the ADP receptor P2Y 1 .
To date, investigators have focused predominantly on characterizing the potential role of P2Y 14 in the regulation of immune function (20) , (15) , (18) , (17) , (19) . It has been reported that P2RY14 mRNA is detectable at relatively high levels in human stomach and intestine, with only placenta and adipose tissue expressing greater amounts (6) , (15) . We sought to further characterize P2Y 14 in the GI tract by determining the expression of the receptor in the rodent gut and examining the effect of cognate agonists and gene ablation on stomach motility.
MATERIALS AND METHODS

Animals
All animals were maintained on a 12 hour light/12 hour dark phase schedule with free access to food and water. All experimental procedures were performed according to the UK Animals (Scientific Procedures) Act of 1986 and were approved by the GlaxoSmithKline procedures review panel. All efforts were made to minimise the number of animals used.
Generation of P2Y 14 knockout mice
To generate the targeting construct, 5' and 3' homology arms (3.4kb and 2.7kb respectively) were isolated from a 129 SVj BAC library and inserted either side of a Internal Ribosome Entry SiteLacZ-polyA (IRES-lacZ) expression cassette and a positive selection cassette containing the neomycin phophotransferase gene driven by the phosphoglycerine kinase promoter. Homologous recombination in neomycin-resistant ES cells was confirmed by Southern blot of BamHI-digested genomic DNA using a 5' external probe which detects a ~10 kb band at the wild-type (WT) locus or a 6.8 kb band at the targeted locus. Similarly, targeting at the 3' end of the locus was confirmed by Southern blot of EcoRV-digested genomic DNA using a 3' external probe which detects an ~4.7 kb band at the WT locus or a 3.7kb band at the targeted locus. Gene targeting was performed in E14.1 ES cells (129P2/OlaHsd). Two targeted clones were injected into C57BL/6J-derived blastocysts.
Male chimaeras were crossed with C57BL/6J females to produce N1F0 offspring. The animals carrying the P2ry14 mutant allele from one injected clone were repeatedly bred, or backcrossed, onto the C57BL/6J genetic background for nine generations. Heretozygous animals were then intermated to produce homozygous F1 animals that were either used for phenotypic testing or maintained as separate KO (P2ry14 -/-) or WT (P2ry14
To genotype the mice, genomic DNA was extracted from tail-tips using a mouse tail extraction kit Loss of P2ry14 mRNA in the KO mice was confirmed using the reverse transcription (RT)-PCR.
Total RNA was extracted from 30 mg of tissues isolated from adult P2ry14 -/-or WT mice using an visualized by ethidium bromide staining on a 1% agarose gel after electrophoresis.
later.
Real-time quantitative RT-PCR
Relative quantitative determinations of the distributions in the rat gut and nervous system of P2ry14 mRNA and the internal reference 18S rRNA were performed using the real-time reverse 
Detection of LacZ expression
Adult male WT and P2Y 14 KO mice were euthanized by cervical dislocation, GI regions were dissected, and rinsed in phosphate-buffered saline (PBS) to remove all traces of food and fecal 
Isolated forestomach contractility
Male CD rats (200-300 g) were culled by CO 2 inhalation followed by cervical dislocation.
Stomachs were blunt-dissected and placed in Krebs solution (NaCl 121. The neurones within the tissues were selectively stimulated by EFS using biphasic square-wave pulses of 0.5 ms width, 3 Hz frequency, 25 V applied for 20 s every 40 s, over 30 min periods using multichannel stimulators (Scientifica Ltd., Uckfield, UK). Each period was separated by a 5 min interval and bath solutions were changed. These parameters of EFS consistently evoked nervemediated responses with a good signal-to-noise ratio over spontaneous muscle activity. After obtaining consistent EFS-evoked responses, UDP-glucose (1-100 μM), UDP-galactose (10-100 μM), the 5HT 4 receptor agonist tegaserod (10 μM) or vehicle were applied non-cumulatively to separate tissues (15 min contact) and changes in baseline tension or amplitude of contractions during EFS were measured.
Male WT or P2Y 14 KO mice (25-30 g) were culled by concussion followed by cervical dislocation and forestomach circular muscle preparations were prepared as described above for longitudinal preparations but with the different dissection orientation (in mice, forestomach circular muscle preparations produce more consistent responses to electrical stimulation than longitudinal muscle preparations, while the opposite is true for rat forestomach muscle preparations). After obtaining consistent responses to EFS (0.5 ms width, 5 Hz frequency, 50 V, 30 s every 120 s), 100 μM or 300 μM UDP-glucose or vehicle was applied and changes in the amplitude of contractions during EFS were measured. In a separate set of experiments, the effect of 100 μM UDP-glucose on resting muscle tension was assessed in the absence of electrical stimulation and in the presence of 1 μM tetrodotoxin (TTX) and 1 μM atropine to block nerve-mediated contractions.
MP100 hardware and AcqKnowledge ® software (Biopac Systems, Inc., Santa Barbara, CA, USA) was used. Effects on contractions during the period of EFS were expressed as the maximum amplitude change (mN) of the contraction with maximum effect following drug application relative to the mean of three pre-treatment contractions. Effects on baseline muscle tension were measured as change in tension (mN). Data are presented as means ± SEM.
Gastric emptying
Gastric emptying in rats and mice was determined through measuring the emptying of a nutrient meal (10 g methylcellulose in 200 ml distilled water added to 100 ml distilled water containing 16 g casein, 8 g sucrose, 8 g cornflour and 2 beef bouillon cubes) from the stomach.
To investigate the effect of UDP-glucose on gastric emptying, male CD rats (202-239 g; Charles River, Margate, UK) were acclimatised to being singly-housed in cages for at least 3 days before experimental use (as described in (10)). The animals were fasted overnight before the experiment, but were allowed free access to drinking water at all times. On the day of the experiment, UDPglucose dissolved in 0.9% w/v sodium chloride was administered by intraperitoneal injection (i.p.)
at 500, 1000 and 2000 mg/kg in a total volume of 2 ml/kg (the highest dose of UDP-glucose was based on a published pharmakinetic study in mice (8)). Control animals received 0.9% w/v sodium chloride (saline) i.p.. 10 minutes later, 3 ml of the nutrient meal was administered orally. The syringe and oral dosing-tube were weighed before and after administration of the meal, to determine the exact weight of the administered meal to each animal. 1 hour later each animal was euthanized by exposure to a rising concentration of carbon dioxide in an euthanasia chamber, the abdominal cavity exposed and thread ligatures tied around the cardiac and pyloric sphincters of the stomach.
The stomach was excised from the animal, gently dried with tissue to absorb any excess moisture, and weighed. Each stomach was then cut open along the greater curvature, the contents removed by gently shaking the stomach in a beaker of water, the stomach carefully dried with tissue as before, and the stomach was reweighed. The difference between the weight of the full and empty stomach, which was a measure of the amount of the nutrient meal remaining in the stomach, was subtracted from the weight of the meal administered, to yield the quantity emptied from the stomach during the test period.
To determine the effect of UDP-glucose, D-glucose and gene ablation on gastric emptying in mice, adult male WT and P2Y 14 KO mice (21-29 g; generated by GlaxoSmithKline) were acclimatised to being singly-housed in grid-bottomed cages for at least 3 days before experimental use. The animals were fasted for 6 hours on the experiment day, but allowed free access to drinking water at all the voltage-dependent sodium channel blocker TTX was supplied by Tocris, Bristol, UK; and tegaserod was supplied by GlaxoSmithKline. All drugs were freshly prepared before use. Tegaserod was dissolved in DMSO; all other chemicals were dissolved in distilled water or saline.
Statistical Analysis
Data are presented as means ± SE unless otherwise stated, with n representing the number of animals used. The results of the in vitro isolated tissue studies were analysed by Student's unpaired t test or one-way ANOVA followed by Fisher's Least Significant Difference (LSD) test. The results of the rat gastric emptying experiment were analyzed by one-way ANOVA followed by Dunnett's test. The results of the mouse gastric emptying experiment, with a more complex design and two reference groups for pairwise comparisons, were analyzed using one-way ANOVA followed by
Fisher's LSD test with a Hochberg adjustment for the five planned comparisons. All statistical analyses were performed using STATISTICA 6.1 (StatSoft, Inc., Tulsa, OK, USA) except for the mouse gastric emptying experiment, where SAS 9.1.3 (SAS Institute Inc., Cary, NC, USA) was used. P < 0.05 was considered statistically significant.
RESULTS
P2ry14 mRNA expression
P2ry14 mRNA was detected throughout the rat gastrointestinal tract by real-time RT-PCR, the highest level being in the forestomach with the levels in the other full-thickness gut regions being 63-95% lower (Fig. 1); . The expression levels in the LMMP versus the mucosa from three regions were compared and found to be higher in the LMMP in all three, the fold-change being 1.58 in the duodenum, 29.65 in the ileum and 29.08 in the colon. The normalized mRNA was also detected in the whole brain and lumbosacral spinal cord at 17.0 ± 2.2% and 6.9 ± 1.0% of the level in the forestomach, respectively. The transcript was also detectable in the vagus nerve and in sensory ganglia but at low expression levels (0.9 -2.2% of the level in the forestomach).
Generation of P2Y 14 KO mice
The 
P2ry14
-/-mice were viable and born in normal Mendelian ratios. RT-PCR analysis of three selected control tissues (oesophagus, brain and lung) confirmed that while P2ry14 transcripts were observed in the mRNA isolated from WT tissues, no such transcripts were detectable in mRNA isolated from the P2ry14 -/-tissues (Fig. 2B ).
LacZ expression in the forestomach
The replacement of the P2ry14 gene in the KO mice with a targeting construct containing the coding region for the bacterial LacZ reporter gene meant that normal P2Y 14 protein expression within the stomach could be indicated by using X-gal, a substrate for β-galactosidase, to produce blue staining wherever β-galactosidase, the product of LacZ, was expressed. In the homozygous KO mice, pronounced blue staining was identified in the muscularis externa, muscularis mucosae and mucosa of the forestomach (as indicated by the arrows in Fig. 3 ; for the colour version of Fig. 3 , see DATA SUPPLEMENTS), with no staining in the forestomach from WT animals. However, even though there was an absence of pronounced staining in the WT mice, we cannot completely rule out the possibility that the mucosal staining was an artefact due to the β-galactosidase activity of residual bacteria contaminating the tissue.
UDP-glucose and UDP-galactose produced contractile effects on rat isolated forestomach
In rat forestomach preparations, both UDP-glucose (1-100 μM) and UDP-galactose (10-100 μM)
increased the baseline muscle tension (e.g. increases of 6.22 ± 0.55 and 1.60 ± 0.59 mN at 100 μM, P < 0.05, n=3-4; Fig. 4A ; Table 1 ). Both agonists also increased the amplitude of contractions during EFS (e.g. amplitudes were increased by 3.70 ± 1.67 and 4.34 ± 2.55 mN upon application of 100 μM UDP-glucose or UDP-galactose respectively, P < 0.05, n=3-4A; Table 1 ). The onset of these effects was rapid and the maximal effect was often observed in the first or second contraction following drug treatment (Fig. 4A ). 10 μM tegaserod had no contractile effect on the baseline muscle tension, whereas conversely, it induced a significant muscle relaxation of 2.03 ± 0.65 mN (P < 0.05 compared to vehicle controls, n=8; Table 1 ). 10 μM tegaserod also induced an increase in the amplitude of EFS-induced contractions of 3.39 ± 0.85 mN (P < 0.05 compared to vehicle, n=8; Table 1 ). It is unclear whether the apparent UDP-glucose and UDP-galactose-induced increase of contraction amplitude during EFS represented a direct effect on a neuronal response or was a consequence of the simultaneous increase in the baseline muscle tension.
UDP-glucose effects on mouse isolated forestomach were lost in KO mice
EFS-evoked responses in isolated forestomach circular muscle preparations have been previously characterised for C57BL/6J mice (3) and the responses using tissues from WT and P2Y 14 KO mice were observed to have similar characteristics. In summary, these consist of an initial small contraction followed by either a relaxation or a further contraction during EFS. Termination of EFS immediately and consistently evoked a large-amplitude 'after-contraction'. All EFS-evoked responses were prevented by 1 μM tetrodotoxin. As termination of EFS consistently evoked aftercontractions, the effects of treatments were assessed for their ability to modulate this component of the EFS-induced response.
100 μM UDP-glucose caused a significant increase in baseline muscle tension in WT but not P2Y 14 KO mouse isolated circular forestomach preparations compared to vehicle controls (0.95 ± 0.05 mN, P < 0.05 and -0.14 ± 0.07 mN, P > 0.05, respectively; n=6 each; Fig. 5A ) in the presence of TTX and atropine to block nerve-mediated contractions. 100 μM UDP-glucose also significantly increased the amplitude of the EFS-induced after-contractions in WT but not P2Y 14 KO mouse isolated circular forestomach preparations (0.87 ± 0.40 mN, P < 0.05 and 0.03 ± 0.24 mN, P > 0.05, respectively; n=6 each; Fig. 5B ). Similar to the rat, this UDP-glucose-induced effect on EFSinduced contractions in the wild-type mice may have been influenced by the simultaneous increase in baseline muscle tension (Fig. 4B) . Additionally, as observed in the rat, the UDP-glucose-induced increases were immediate, with maximal effects observed within the first 1-2 minutes of application (Fig. 4B) . The effects were also short lived, with activity returning to pre-drug levels within the 15 min application period (Fig. 4B) .
UDP-glucose reduced gastric emptying in the conscious rat
UDP-glucose treatment at 2000 mg/kg reduced gastric emptying of the nutrient meal by 50% from 32.84 ± 3.80% of the meal emptied to 16.53 ± 2.85% (P < 0.05, n=6) after 60 min, with no significant effect of UDP-glucose treatment at the lower doses (P = 0.949 & 0.985, respectively, n=4-6; Fig. 6 ).
Gastric Emptying in WT and P2Y 14 KO Mice
There was no significant difference in the % emptied from the stomachs in the WT or the KO mice (36.79 ± 4.34%, n=10 versus 37.17 ± 3.94%, P = 0.958, n=7; Fig. 7) . As a percentage of the levels in the saline-controls, 2000 mg/kg UDP-glucose reduced gastric emptying by 56.1% (P < 0.05, n=7-10) in the WT mice and by 66.2% (P < 0.05, n=7) in the KO mice (Fig. 7) . Treatment with 2000 mg/kg D-glucose as a control had no effect on gastric emptying in either the WT or KO mice (P = 0.958 and P = 0.876, respectively, n=6-10; Fig. 7) .
DISCUSSION
In the past, P2Y receptors have been reported to modulate gastrointestinal functions and in this study we aimed to determine whether this extends to the latest member of the family, P2Y 14 . Our observation of P2ry14 mRNA expression throughout the rat gastrointestinal suggests that there may be a role for this receptor in the gastrointestinal system. Additionally, the presence of P2ry14 mRNA expression in the vagus nerve, albeit at relatively low levels, may imply a possible role for the receptor in the control of gastrointestinal reflexes.
As the highest levels of expression were observed in the forestomach, we used this region to investigate the functional effects of the two most potent endogenous ligands at the P2Y 14 receptor, UDP-glucose and UDP-galactose (6), (11) . Experiments were conducted using rat and mouse isolated forestomach using a technique previously developed to detect agents which facilitate electrically-evoked, nerve-mediated contractions, an activity indicative of gastro-prokinetic activity (4),(3). In the rat, UDP-glucose and UDP-galactose each increased EFS-induced, nerve-mediated contractions, an effect which would normally suggest that these UDP-sugars have the ability to increase gastric emptying rates. Indeed, tegaserod, shown here to increase the EFS-induced, nervemediated contractions in the rat, is a motility-enhancing agent that has been effective in the clinic (9) . However, unlike tegaserod, which had no ability to directly contract the muscle, UDP-glucose and UDP-galactose both increased the baseline muscle tension. Therefore, the excitatory effect on nerve-mediated contractions may have been influenced by the simultaneous increase in the resting muscle tension and as such this action is not necessarily predictive of prokinetic activity of UDPglucose and UDP-galactose. In the absence of a selective antagonist for the P2Y 14 receptor, we used P2Y 14 receptor KO mice to help confirm the involvement of this receptor in the in vitro responses. The same pattern of response to UDP-glucose in rat isolated forestomach preparations was observed in similar preparations from WT mice. The generation of KO mice was successful, with no detectable P2ry14 mRNA detected in control tissues by RT-PCR. LacZ staining was observed in the muscularis externa and muscularis mucosae and the mucosal layers in the forestomach of the KO mice, suggesting that P2ry14 gene expression is localised to these layers in WT mice. Certainly, the effect of UDP-glucose observed on muscular contractility in the forestomach supports this localisation pattern. Additionally, the P2Y 14 receptor has been heavily implicated in immune responses (15), (17), (18), (19), (20) In vivo, UDP-glucose treatment at 2000 mg/kg reduced the gastric emptying rate of a nutrient meal in rats and mice. However, unlike the observations made in vitro, the effect of UDP-glucose was not lost in the P2Y 14 KO mice. This may be due to the type of meal used, as it remains a possibility that P2Y 14 receptor activation could affect the gastric emptying of other meal types, such as a liquid non-nutrient meal, where the rate of emptying may be more readily modified by a change in forestomach muscle tension. Alternatively, its possible that this effect could be mediated via GPR17, the only other receptor at which UDP-glucose is reported to act as an agonist (7), and could be investigated through the use of GPR17 KO mice. Another possibility is that the gastric emptying effect may be due to a contaminant in the UDP-glucose preparation, as it has been reported that microbial-derived UDP-glucose but not synthetic UDP-glucose can stimulate iNOS and COX-2 expression in microglia (5) . 
